<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190121042445N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-02-19</date_registration>
      <primary_sponsor>Social Security Hospital</primary_sponsor>
      <public_title>The Effects of Neuromobilization in Patients With Shoulder Impingement Syndrome on Pain,Strength,Range of Motion and Functional disability Score</public_title>
      <acronym>NONE</acronym>
      <scientific_title>The Effects of Neuromobilization in Patients With Shoulder Impingement Syndrome on Pain,Strength,Range of Motion and Functional disability Score.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2637-11-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/37026</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: 80 patients, Randomization description: Single blind randomized clinical trial.The sequence of assignment was determined using a computer generated random sequence table before the study. Individual, sequentially numbered index cards with the random assignment were prepared. The index cards were folded and placed in sealed, opaque envelopes. After the baseline examination, participants were randomly assigned to receive routine physiotherapy or routine physiotherapy plus neurombilization, Blinding description: A single blind randomized clinical trial in which the investigator assessing the outcomes doesn’t know the identity of intervention.</study_design>
      <phase>4</phase>
      <hc_freetext>patients suffering from shoulder impingement syndrome lead impairment of daily activities and reduction in work capacity. Most of patients have painful symptoms at night and during abduction which may affect the sleep and daily activities.Forty percent of the populations possibly suffer from shoulder pain at some point of their life time..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Neuromobilization was applied using Butler’s recommendations.Procedure; Initially, the patient performed neural sliders and gradually progressed to neural tensioners. Neural sliders consisted of cervical lateral flexion movement, toward the involved side, simultaneously with elbow flexion and extension movements. While moving the head in to cervical lateral flexion the elbow was extended. When the elbow began to flex, the cervical spine was returned to neutral. Neural tensioners are the opposite of neural sliders. Neural tensioners are not a stretch and are performed to create tension in the nerve. The tension position is not held for a length of time, but is released by extending the elbow and returning the cervical spine to neutral once the patient had pushed slightly past the  point of initially experiencing pain or discomfort. Neuromobilization technique was performed for 5 sec with 10 repetitions. Intervention 2: Control group: The routine physiotherapy includes pulsed Short wave diathermy, ultrasonic treatment, TENS and shoulder strengthening exercises for rotator cuff muscles and stretching exercises to regain flexibility.Joint and tissue mobilization, motor Control Training, strengthening and stretching exercises were performed for 5 sec with 10 repetitions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The Effects of Neuromobilization in Patients With Shoulder Impingement Syndrome on Strength and Range of Motion.

When:
data will be available when my Ph.D study completed

To whom:
For academic institutions only

Conditions:
People who will request for data

Where to obtain:
through email address

How to obtain:
my email address

Comments:
N/A</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Karimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Defence road</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>53720</zip>
        <telephone>N/A</telephone>
        <email>hkarimi.pt.uos08@gmail.com</email>
        <affiliation>The University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Akhtar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Model Town</address>
        <city>Gujranwala</city>
        <country1>Pakistan</country1>
        <zip>52250</zip>
        <telephone>N/A</telephone>
        <email>a.hunjra@gmail.com</email>
        <affiliation>PESSI</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Positive Impingement Sign
Age Between 20-50 years
Patient with Positive Special Tests (Neers Test, Hawkins Kennedy Test, Empty Can Test)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with co-morbidity such as Cervical Radiculopathy,
Acromioclavicular Joint Pathology and Shoulder Dislocation/ Subluxation/ Fracture.
Patients with history of Cervical, Shoulder of Upper Back Surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Neuromobilization was applied using Butler’s recommendations.Procedure; Initially, the patient performed neural sliders and gradually progressed to neural tensioners. Neural sliders consisted of cervical lateral flexion movement, toward the involved side, simultaneously with elbow flexion and extension movements. While moving the head in to cervical lateral flexion the elbow was extended. When the elbow began to flex, the cervical spine was returned to neutral. Neural tensioners are the opposite of neural sliders. Neural tensioners are not a stretch and are performed to create tension in the nerve. The tension position is not held for a length of time, but is released by extending the elbow and returning the cervical spine to neutral once the patient had pushed slightly past the  point of initially experiencing pain or discomfort. Neuromobilization technique was performed for 5 sec with 10 repetitions.</i_keyword>
      <i_keyword>Control group: The routine physiotherapy includes pulsed Short wave diathermy, ultrasonic treatment, TENS and shoulder strengthening exercises for rotator cuff muscles and stretching exercises to regain flexibility.Joint and tissue mobilization, motor Control Training, strengthening and stretching exercises were performed for 5 sec with 10 repetitions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain Intensity. Timepoint: before intervention, 5th week and 11th week after intervention. Method of measurement: Pain by Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Range of motion. Timepoint: Before intervention, on 5th week and on 11th week. Method of measurement: Measured by Goniometry.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Shoulder Strength. Timepoint: Before intervention, on 5th week and on 11th week. Method of measurement: Strength by Hand held dynamometer.</sec_outcome>
      <sec_outcome>Functional disability score. Timepoint: Before intervention, on 5th week and on 11th week. Method of measurement: UCLA Score.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Social Security Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2637-10-24</approval_date>
        <contact_name>Institutional Review Board, University of Lahore</contact_name>
        <contact_address>Raiwind road Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
